Medicenna Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch MDNAF and buy or sell other stocks, ETFs, and their options commission-free!

About MDNAF

Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company. It engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. 

CEO
Fahar Merchant
CEOFahar Merchant
Employees
18
Employees18
Headquarters
Toronto, Ontario
HeadquartersToronto, Ontario
Founded
2015
Founded2015
Employees
18
Employees18

MDNAF Key Statistics

Market cap
59.20M
Market cap59.20M
Price-Earnings ratio
-7.19
Price-Earnings ratio-7.19
Dividend yield
—
Dividend yield—
Average volume
84.69K
Average volume84.69K
High today
$0.8617
High today$0.8617
Low today
$0.75
Low today$0.75
Open price
$0.765
Open price$0.765
Volume
48.70K
Volume48.70K
52 Week high
$1.94
52 Week high$1.94
52 Week low
$0.5732
52 Week low$0.5732

People also own

Based on the portfolios of people who own MDNAF. This list is generated using Robinhood data, and it’s not a recommendation.
Ocugen, Inc
Ideanomics
Nikola
Plug Power
Lucid Group
SNDL
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.